MedPath
FDA Approval

Betaine Anhydrous for Oral Solution

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
OAKRUM PHARMA, LLC
DUNS: 081507685
Effective Date
November 10, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betaine(1 g in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novitium Pharma LLC

OAKRUM PHARMA, LLC

080301870

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betaine Anhydrous for Oral Solution

Product Details

NDC Product Code
72647-900
Application Number
ANDA214864
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 10, 2022
BetaineActive
Code: 3SCV180C9WClass: ACTIBQuantity: 1 g in 1 g
© Copyright 2025. All Rights Reserved by MedPath